GlaxoSmithKline PLC — Director's Dealing 2016

Jul 12, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9949D

GlaxoSmithKline PLC

12 July 2016

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mrs V A Whyte

b)

Position/status

Company Secretary

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each

ISIN: GB0009252882

b)

Nature of the transaction

Following the vesting on 8 July 2016 of 25% of an award made on 8 July 2010 under the GlaxoSmithKline Deferred Investment Award Plan, Mrs Whyte will receive a cash payment of 1645.25 pence per ordinary share in respect of 4,034.1312 notional ordinary shares.

c)

Price(s) and v

olume(s)

Price(s)	Volume(s)
£16.4525	4,034.1312 notional ordinary shares.

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

e)

Date of the transaction

2016-07-08

f)

Place of the transaction

n/a

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHQLLFFQDFFBBV